Literature DB >> 2272047

Batanopride (BMY-25801): a new 5-HT3 receptor antagonist for the prevention of cancer chemotherapy-induced emesis.

L Smaldone1, P Plezia, D Alberts, M Aapro, G Sartiano, M Dorn, M Brady, C Comerski, S E Schwartz, C Fairchild.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2272047     DOI： 10.1016/0305-7372(90)90064-m

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN： 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  1 in total

1.  The disposition and protein binding of batanopride and its metabolites in subjects with renal impairment.

Authors:  J V St Peter; M E Brady; E F Foote; K A Dandekar; L Smaldone; J L Pykkonen; W F Keane; C E Halstenson
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.